Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients

CC BY-NC-ND 4.0 · South Asian J Cancer 2018; 07(04): 218
DOI: 10.4103/sajc.sajc_53_18

Letter to the Editor

Authors

Vishwanath Singh Yadav

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
Bimal K. Das

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
Hitender Gautam

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
Seema Sood

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
Arti Kapil

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
Sarita Mohapatra

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India

References
1 Mandell GL, Dolin R. Principles and Practice of Infective Disease. 6^th ed. New York: Elsevier; 2005. p. 2757-9.
2 Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol 2005;43:2021-3.
3 Monteen MR, Ponnapula S, Wood GC, Croce MA, Swanson JM, Boucher BA, et al. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient. Ann Pharmacother 2013;47:1736-9.
4 Bhuyar G, Jain S, Shah H, Mehta VK. Urinary tract infection by Chryseobacterium indologenes. Indian J Med Microbiol 2012;30:370-2.
5 Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997;41:2738-41.